Using Genetic Polymorphisms of Drug Metabolism and Immunohistochemical Stain to Predict the Efficacy and Toxicity in Patients With Gastric Adenocarcinoma - A Phase II Study
Phase of Trial: Phase II
Latest Information Update: 06 May 2016
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Oxaliplatin (Primary) ; Cisplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 03 May 2016 Status changed from recruiting to discontinued due to budget issues.
- 29 Oct 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Mar 2012 New trial record